Heron Therapeutics shares owned by Group One Trading
Quarter-by-quarter ownership of Heron Therapeutics shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Heron Therapeutics by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $84k | 42k | 1.99 |
| 2024-06-30 | $147k | 42k | 3.50 |
| 2024-03-31 | $2.5M | 909k | 2.77 |
| 2023-09-30 | $969k | 941k | 1.03 |
| 2023-06-30 | $696 | 600 | 1.16 |
| 2023-03-31 | $1.2k | 800 | 1.51 |
| 2022-12-31 | $5.8k | 2.3k | 2.50 |
| 2022-09-30 | $13k | 3.0k | 4.33 |
| 2022-06-30 | $33k | 12k | 2.82 |
| 2022-03-31 | $299k | 52k | 5.72 |
| 2021-12-31 | $160k | 18k | 9.14 |
| 2021-09-30 | $791k | 74k | 10.69 |
| 2021-06-30 | $1.4M | 91k | 15.52 |
| 2021-03-31 | $1.4M | 84k | 16.21 |
| 2020-12-31 | $571k | 27k | 21.15 |
| 2020-09-30 | $405k | 27k | 14.84 |
| 2020-06-30 | $1.4M | 93k | 14.72 |
| 2020-03-31 | $1.4M | 119k | 11.74 |
| 2019-12-31 | $684k | 29k | 23.51 |
| 2019-09-30 | $477k | 26k | 18.49 |
| 2019-06-30 | $472k | 25k | 18.58 |
| 2019-03-31 | $501k | 21k | 24.44 |
| 2018-12-31 | $1.0M | 40k | 25.94 |
| 2018-09-30 | $2.8M | 87k | 31.65 |
| 2018-06-30 | $1.2M | 31k | 38.84 |
| 2018-03-31 | $2.2M | 81k | 27.61 |
| 2017-12-31 | $695k | 38k | 18.10 |
| 2017-09-30 | $1.1M | 69k | 16.15 |
| 2017-06-30 | $42k | 3.0k | 14.00 |
| 2017-03-31 | $86k | 5.7k | 15.09 |
| 2016-12-31 | $639k | 49k | 13.09 |
| 2016-09-30 | $662k | 38k | 17.24 |
| 2016-06-30 | $682k | 38k | 18.04 |
| 2016-03-31 | $940k | 50k | 18.99 |
| 2015-12-31 | $497k | 19k | 26.72 |
| 2015-09-30 | $9.8M | 403k | 24.40 |
| 2015-06-30 | $5.8M | 186k | 31.16 |
| 2015-03-31 | $898k | 62k | 14.55 |
| 2014-09-30 | $8.0k | 1.0k | 8.00 |
Top funds holding Heron Therapeutics
View all funds holding Heron Therapeutics